Hepatitis C eradication: A long way to go

A path to eradication of hepatitis C in low- and middle-income countries

(2015) Camilla S. Graham et al.   ANTIVIRAL RESEARCH

Hepatitis C: only a step away from elimination?

(2015) The Lancet   LANCET

Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study

(2015) Sunil Suhas Solomon et al.   LANCET INFECTIOUS DISEASES

Effect of interferon plus ribavirin therapy on hepatitis C virus genotype 3 patients from Pakistan: Treatment response, side effects and future prospective

(2015) Yasir Waheed   Asian Pacific Journal of Tropical Medicine

Hepatitis C drug affordability

(2015) Mohga Kamal-Yanni   Lancet Global Health

Can hepatitis C be eradicated in the United States?

(2014) Brian R. Edlin et al.   ANTIVIRAL RESEARCH

Minimum Costs for Producing Hepatitis C Direct-Acting Antivirals for Use in Large-Scale Treatment Access Programs in Developing Countries

(2014) A. Hill et al.   CLINICAL INFECTIOUS DISEASES

Strategies to manage hepatitis C virus (HCV) disease burden

(2014) H. Wedemeyer et al.   JOURNAL OF VIRAL HEPATITIS

Treating Hepatitis C in Lower-Income Countries

(2014) Channa R. Jayasekera et al.   NEW ENGLAND JOURNAL OF MEDICINE

Current testing strategies for hepatitis C virus infection in blood donors and the way forward

(2014) Neelam Marwaha   WORLD JOURNAL OF GASTROENTEROLOGY

The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in U.S. Primary Care Settings

(2013) David B. Rein et al.   ANNALS OF INTERNAL MEDICINE

Global Burden of Hepatitis C: Considerations for Healthcare Providers in the United States

(2012) Francisco M. Averhoff et al.   CLINICAL INFECTIOUS DISEASES